Beauty Boom: What’s driving the aesthetics growth in emerging markets?
Helen Ansell explores why aesthetics is one of the most lucrative areas for the pharmaceutical and healthcare industries in emerging markets.
Aesthetics have always been a lucrative area for the pharmaceutical and healthcare industries, particularly in developed markets. There are several factors contributing to growth in the aesthetics market. Women today have more spending power than ever before. In the US alone the aesthetics market is expected to reach USD $4.4 billion by 2021. However, what has really grabbed my attention as a researcher specialising in emerging markets and cosmetics, is the huge growth in demand in developing markets over the past few years, strongly reinforcing the opportunities for healthcare companies across the globe.
Can virtual reality revolutionise the way we conduct healthcare market research?
In the final installment of a three-part series exploring immersive technologies, Harrison Gaiger looks at how technological advances in VR/AR are offering new opportunities for conducting healthcare market research.
Given the powerful impact of VR/AR technology and its expanding applications within the healthcare industry, it is easy to imagine the many ways in which VR/AR can be utilised to develop, research, and evaluate product and service innovations. Instead of simply observing how respondents behave, pharmaceutical and MedTech companies now have the ability to understand the reasons why with greater clarity. VR/AR technology presents market researchers with an opportunity to study customers’ behaviour in more depth than ever before and can provide insights that complement those gathered using traditional market research techniques, such as surveys and focus groups.
Dónde estoy, onde estou, où suis-je, where am I?
Defining the regions of Latin America and the Caribbean
Although we have conducted a lot of research studies in Latin America and the Caribbean, we couldn’t, as a team, agree exactly what defines this region and its boundaries for our clients. This is because our clients structure their LATC divisions in different ways. They often decide how to structure themselves based on where the best talent is located within the region and then balance that against proximity to strategic regions and US offices. As a result LATC operational teams vary by organisation. There is no standard blue print.
A common reality: How augmented reality is transforming the future of pharmaceutical marketing
In the second installment of a three-part series exploring virtual and augmented reality, Harrison Gaiger explores the ways in which AR is transforming the future of pharmaceutical marketing.
In a previous article I explored the growing role that Virtual Reality (VR) is playing in the healthcare industry, including its use as a marketing tool for pharmaceutical companies, and questioned what the future of VR may look like in a world where technological advancements are being made every day. It seemed clear to me that while VR is still in the early stages of medical application, it’s already making a huge impact on the healthcare industry and that, regardless of its infancy, VR technology is most likely here to stay. Because of this I concluded by saying that tech-savvy pharmaceutical marketers should consider adding it to their future strategies as an invaluable means for engaging with customers. In the second instalment of this three-part series, I look at the ways in which Augmented Reality (AR) is transforming the future of pharmaceutical marketing.
Comparing apples and oranges: Is a global segmentation transferable?
When our clients are considering primary market research in emerging markets they typically face two challenges - a lack of good local data and budget.
The absence of reliable and up-to-date information in emerging markets should mean that a greater budget is allocated to primary market research. However, in reality the opposite is true. Consequently, our clients want to know if they can tailor global studies to reflect the nuances of different emerging markets.